BRILINTA
Ticagrelor
- Strength
- 90 mg/1
- Form
- Tablet
- Class
- P2Y12 Platelet Inhibitor
Cardinal Health 107, LLC
Not stocked by us — reference only
Listed by Aphena Pharma Solutions - Tennessee, LLC
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | P2Y12 Platelet Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 71610-958 |
| FDA application | ANDA208584 |
| RxNorm concept | 1116635 |
| Package sizes listed | 2 |
| Marketed since | May 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Ticagrelor
Cardinal Health 107, LLC
Not stocked by us — reference only
Ticagrelor
Aphena Pharma Solutions - Tennessee, LLC
Not stocked by us — reference only
Ticagrelor
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
Ticagrelor
AstraZeneca Pharmaceuticals LP
Not stocked by us — reference only
Oryza Pharmaceuticals, Inc.
Not stocked by us — reference only
AvKARE
Not stocked by us — reference only
Apotex Corp.
Not stocked by us — reference only
Cipla USA Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.